| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $616.6M | +11.4% |
| Cost of Revenue | $127.9M | +11.2% |
| Gross Profit | $488.7M | +11.4% |
| R&D Expense | $117.1M | +17.4% |
| SG&A Expense | $77.9M | -3.1% |
| Operating Income | $267.1M | +17.3% |
| Pre-tax Income | $268.2M | +17.5% |
| Income Tax | $58.2M | +32.1% |
| Net Income | $210.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.4M | -70.1% |
| Short-term Investments | $484.3M | +37.9% |
| Accounts Receivable | $92.7M | -13.9% |
| Inventory | $183.2M | +36.6% |
| Current Assets | $899.5M | -2.9% |
| Total Assets | $1.53B | +4.5% |
| Current Liabilities | $135.7M | -27.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $126.8M | -33.6% |
| Capital Expenditures | $42.5M | -1.5% |
| Investing Cash Flow | -$280.7M | +38.7% |
| Financing Cash Flow | -$64.6M | -25.8% |
| Free Cash Flow | $84.3M | -43.0% |
| +14.0% |
| EPS (Basic) | $4.41 | +14.0% |
| EPS (Diluted) | $4.40 | +13.7% |
| Total Liabilities |
| $257.5M |
| -29.9% |
| Stockholders' Equity | $1.28B | +16.0% |